Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 53, 2023 - Issue 4
109
Views
3
CrossRef citations to date
0
Altmetric
Articles

Synthesis, characterization and biological evaluation of the novel chromenopyridothiazolopyrimidines and chromenopyridopyrimidothiazolo-pyrimidines

ORCID Icon & ORCID Icon
Pages 332-344 | Received 16 Dec 2022, Published online: 28 Jan 2023
 

Abstract

Friedländer reaction of 4-aminocoumarin-3-carboxaldehyde (1) with thiobarbituric acid provided 2-thioxochromenopyridopyrimidine 2 which employed as a synthetic intermediate to create a novel annulated chromenopyridothiazolopyrimidines. Treatment of compound 2 with a diversity of nucleophiles including; dibromoethane, oxalyl chloride, phenacyl bromide, chloroacetic acid, 3-chloropentanedione, ethyl 2-chloro-3-oxobutanoate, chloroacetonitrile and bromomalononitrile afforded chromenopyridothiazolopyrimidines 3–10, respectively. Acidic hydrolysis of carbonitrile 10 afforded the corresponding carboxamide derivative 11. Compound 11 reacted with some mono-electrophilic reagents namely acetyl chloride, benzoyl chloride, chloroacetyl chloride, triethyl orthoformate, diethyl carbonate, and carbon disulfide producing the first known chromeno[3′,4′:5,6]pyrido[2,3-d]pyrimido [4',5':4,5][1,3]thiazolo[3,2-a]pyrimidines 12–17. The antimicrobial and anticancer activities were estimated for the synthesized products and some of them appeared notable activities. The structural elucidation of the newly synthesized products was determined using analytical and spectroscopic data.

Graphical Abstract

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.